In last trading session, Revelation Biosciences Inc (NASDAQ:REVB) saw 0.37 million shares changing hands with its beta currently measuring -0.06. Company’s recent per share price level of $2.95 trading at $0.11 or 3.87% at ring of the bell on the day assigns it a market valuation of $4.53M. That closing price of REVB’s stock is at a discount of -5594.92% from its 52-week high price of $168.00 and is indicating a premium of 28.47% from its 52-week low price of $2.11. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.28 million shares which gives us an average trading volume of 410.65K if we extend that period to 3-months.

For Revelation Biosciences Inc (REVB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -1.49 in the current quarter.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

Revelation Biosciences Inc’s shares saw a change of -96.70% in year-to-date performance and have moved 5.73% in past 5-day. Revelation Biosciences Inc (NASDAQ:REVB) showed a performance of 24.47% in past 30-days. Number of shares sold short was 0.15 million shares which calculate 0.06 days to cover the short interests.

Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders

Insiders are in possession of 2.27% of company’s total shares while institution are holding 1.70 percent of that, with stock having share float percentage of 1.74%. Investors also watch the number of corporate investors in a company very closely, which is 1.70% institutions for Revelation Biosciences Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 1.14 shares of worth $3348.0 or 0.02% of the total outstanding shares. The later fund manager was in possession of 309.0 shares on May 31, 2025 , making its stake of worth around $911.0 in the company or a holder of 0.01% of company’s stock.